IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Novasep Expands Its HPAPI Manufacturing Facility in France

11:32 AM MDT | July 19, 2012 | Sotirios Frantzanas

Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPI) manufacturing capabilities at the company's Le Mans, France facility. The amount of the investment is €3 million ($3.7 million), and the plant expansion is expected to be fully operational by the beginning of 2013, the company says. There is a sharp increase in demand for "targeted and potent" drugs that improve efficacy and reduce side effects, such as antibody-drug conjugates (ADC), Novasep says. The expansion of Novasep's Le Mans...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa